Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M390Revenue $M54.2Net Margin (%)-104.0Altman Z-Score-5.5
Enterprise Value $M482EPS $-0.4Operating Margin %-164.7Piotroski F-Score4
P/E(ttm)--Beneish M-Score-2.8Pre-tax Margin (%)-110.3Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio4.1Cash flow > EarningsY
Price/Sales6.55-y EBITDA Growth Rate %-20.3Current Ratio4.5Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-30.8Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M177ROIC % (ttm)-564.3Gross Margin Increase y-yY

Gurus Latest Trades with AMRN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AMRNGeorge Soros 2012-09-30 Sold Out -0.06%$11.17 - $15.49
($13.55)
$ 2.18-84%Sold Out0
AMRNGeorge Soros 2012-06-30 Buy 0.06%$9.47 - $14.74
($11.35)
$ 2.18-81%New holding300,000
AMRNGeorge Soros 2011-09-30 Sold Out -0.058%$8.95 - $14.82
($12)
$ 2.18-82%Sold Out0
AMRNGeorge Soros 2011-06-30 Reduce-0.04%$7.39 - $19.5
($15)
$ 2.18-85%Reduce 56.15%285,000
AMRNGeorge Soros 2011-03-31 Reduce-0.04%$7.03 - $9.33
($8.1)
$ 2.18-73%Reduce 42.66%650,000
AMRNGeorge Soros 2010-12-31 Buy 0.12%$2.49 - $8.49
($4.48)
$ 2.18-51%New holding1,133,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AMRN is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


AMRN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
THERO JOHN FPresident, Chief Exec. Officer 2014-11-12Buy50,000$0.83162.65 view
Farrell Michael JamesController 2014-11-11Buy5,500$0.84159.52 view
Southpoint Capital Advisors LP10% Owner 2006-04-20Sell0$0159.52 view

Quarterly/Annual Reports about AMRN:

    News about AMRN:

    Articles On GuruFocus.com
    Morning Coffee: Widely Held International Guru Stocks Near 52-Week Lows May 23 2014 
    Weekly Guru Bargains Highlights: PANL, THRX, ZNGA, LORL, AMRN Jan 07 2013 
    Steven Cohen Adds Amarin Corp. Awaiting Drug Approval, Buys Hyatt Hotels Mar 28 2012 
    Soros Funds’ Great Britain Buys and Sells Apr 13 2011 

    More From Other Websites
    Amarin to Report Second Quarter 2015 Results and Host Conference Call on August 6, 2015 Jul 30 2015
    Amarin to Report Second Quarter 2015 Results and Host Conference Call on August 6, 2015 Jul 30 2015
    AMARIN CORP PLC\UK Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale... Jul 10 2015
    New In Vitro Eicosapentaenoic Acid Study Data to Be Presented at the National Lipid Association... Jun 11 2015
    New In Vitro Eicosapentaenoic Acid Study Data Presented June 6 at the American Diabetes Association... Jun 08 2015
    New In Vitro Eicosapentaenoic Acid Study Data Presented June 6 at the American Diabetes Association... Jun 08 2015
    Matinas and Amarin's Destinies are Linked as MAT9001 Outshines Vascepa Jun 03 2015
    AMARIN CORP PLC\UK Files SEC form 8-K, Other Events May 29 2015
    Amarin (AMRN) in Focus: Stock Surges 19% in Session - Tale of the Tape May 29 2015
    What Biotechnology Stocks Will Be Next To Enjoy The Bull Market? May 29 2015
    Amarin's Lawsuit Could Have Huge Benefits For Pharma Industry And Dire Consequences For Consumers May 28 2015
    Amarin Granted Summary Judgment Motion in Suit Against FDA Seeking New Chemical Entity Market... May 28 2015
    Amarin Granted Summary Judgment Motion in Suit Against FDA Seeking New Chemical Entity Market... May 28 2015
    U.S. court grants exclusivity for Amarin's Vascepa May 28 2015
    Amarin to Present at the Jefferies 2015 Global Healthcare Conference May 26 2015
    Amarin to Present at the Jefferies 2015 Global Healthcare Conference May 26 2015
    Why Amarin Corporation (AMRN) Could Be Positioned for a Slump - Tale of the Tape May 18 2015
    AMARIN CORP PLC\UK Financials May 15 2015
    Secret Letter To Doctors Shows That The Amarin Lawsuit Is About Marketing, Not Free Speech May 08 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK